🟢 Citius Pharmaceuticals is trading 5.71% up in pre-market after prior session’s sharp decline

Citius Pharmaceuticals is trading 5.71% up at $0.59, appearing to make a tentative recovery after the prior session’s sharp decline.

• It fell 25.62% to $0.56 on August 17, 2026.
• No new company-specific announcement or overnight catalyst clearly explains the pre-market rebound.
• The August 14 fiscal third-quarter report highlighted accelerating LYMPHIR adoption but also a tight November cash runway.